Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HYPR
HYPR logo

HYPR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.750
Open
1.690
VWAP
1.71
Vol
354.18K
Mkt Cap
166.50M
Low
1.675
Amount
603.88K
EV/EBITDA(TTM)
--
Total Shares
98.52M
EV
131.41M
EV/OCF(TTM)
--
P/S(TTM)
10.19
Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
Show More

Events Timeline

(ET)
2026-04-29
08:20:00
Hyperfine and AIIMS New Delhi Launch Clinical Use of Swoop Portable MRI System
select
2026-04-09 (ET)
2026-04-09
08:40:00
Hyperfine Receives CE Marking and UKCA Approval
select
2026-03-23 (ET)
2026-03-23
08:10:00
Horizon Technology Provides $40M Loan to Hyperfine
select
2026-03-18 (ET)
2026-03-18
16:10:00
Hyperfine Reports Q4 Revenue of $5.29M
select
2026-01-20 (ET)
2026-01-20
08:20:00
Hyperfine Announces NEURO PMR Study Results, Portable MRI Shows Superiority
select
2026-01-15 (ET)
2026-01-15
08:20:00
Hyperfine Enrolls First Patient in Contrast PMR Study
select

News

CNBC
6.0
04-29CNBC
Latest Wall Street Rating Updates
  • Starbucks Rating Maintained: Morgan Stanley reiterates its overweight rating on Starbucks, indicating that the ongoing debate about the company's earnings power reflects an improving narrative that may attract more investor interest.
  • Robinhood Outlook Positive: Bernstein maintains an outperform rating on Robinhood, noting that HOOD stock marked a bottom in Q1 and has started strong in April, suggesting increasing market confidence in its future.
  • CoreWeave Price Target Raised: Wells Fargo raises CoreWeave's price target from $125 to $135, believing that the company's leading position in AI infrastructure will allow it to benefit as demand continues to outpace supply.
  • Telecom Argentina Upgrade: JPMorgan upgrades Telecom Argentina from neutral to overweight, expecting substantial benefits from market consolidation as the antitrust review of its acquisition of Telefonica Argentina nears completion.
Newsfilter
8.5
04-29Newsfilter
AIIMS New Delhi Launches Portable MRI System for Clinical Use
  • Clinical Use Initiated: AIIMS New Delhi, in partnership with Radiosurgery Global India, has begun clinical use of the Hyperfine Swoop® portable MRI system, marking a significant milestone in neurological care that is expected to greatly enhance imaging efficiency for emergency and critically ill patients.
  • Significant Technical Advantages: The Swoop® system eliminates the need for dedicated rooms or patient transport, allowing for bedside brain imaging in ICUs and trauma centers, thereby removing the risks associated with traditional MRI transport and improving diagnostic speed and patient outcomes.
  • Broad Clinical Impact: This system addresses unmet clinical needs across neurology, trauma care, and critical care, particularly in providing rapid assessment for acute stroke and traumatic brain injury, delivering essential imaging support at critical moments.
  • Platform for Research and Innovation: The deployment at AIIMS New Delhi establishes a foundation for clinical research, with plans to document outcomes and advance the adoption of portable MRI in India, enhancing the country's role in the global brain imaging landscape.
PRnewswire
7.5
03-27PRnewswire
Heart Disease Crisis Fuels AI Diagnostic Platforms
  • Economic Burden of Heart Disease: Heart disease costs the European Union over €282 billion annually and claims 1.7 million lives, driving institutional capital to rapidly invest in scalable AI diagnostic platforms, highlighting the urgent market demand for innovative healthcare solutions.
  • Growth of AI Medical Devices: The FDA has approved over 1,200 AI medical devices, with cardiovascular applications emerging as the second largest category, indicating a strong alignment between regulatory support and clinical needs, providing a favorable environment for AI-driven medical technologies.
  • Remote Healthcare Collaboration: VentriPoint Diagnostics is partnering with First Light Health to deliver AI cardiac diagnostics in remote Canadian communities, utilizing the VMS+™ system to enable local providers to collaborate with central specialists, significantly enhancing healthcare accessibility in underserved areas.
  • Potential for Technological Expansion: VentriPoint's VMS+™ system converts standard 2D echocardiograms into 3D volumetric images with accuracy comparable to cardiac MRI, which is expected to drive widespread adoption in underserved communities globally, addressing critical gaps in heart disease diagnosis.
Newsfilter
7.5
03-27Newsfilter
Heart Disease Crisis Fuels AI Diagnostic Platforms
  • Economic Burden of Heart Disease: Heart disease costs the European Union over €282 billion annually and claims 1.7 million lives each year, driving institutional capital towards scalable AI diagnostic platforms, highlighting the urgent market demand for innovative healthcare solutions.
  • Growth in AI Medical Device Registrations: The FDA has approved over 1,200 AI medical devices, with cardiovascular applications emerging as the second-largest category, providing a robust regulatory foundation that supports the rapid growth of companies in this sector.
  • Remote Healthcare Collaboration: VentriPoint Diagnostics has partnered with First Light Health to deliver AI-powered cardiac diagnostics to Indigenous and remote communities in Canada, utilizing the VMS+™ system to enhance accessibility and efficiency in healthcare delivery.
  • Technological Innovation and Market Expansion: VentriPoint's VMS+™ system converts standard 2D echocardiograms into 3D volumetric images with MRI-level accuracy at a lower cost, positioning the company to expand into underserved global communities and address significant gaps in heart disease diagnosis.
Yahoo Finance
8.5
03-24Yahoo Finance
Hyperfine Secures $40M Loan for Swoop System Expansion
  • Funding Support: Hyperfine has secured a $40 million loan from Horizon Technology, with an initial $15 million available at closing and up to $25 million for future commercial initiatives, significantly enhancing the market competitiveness of its Swoop system.
  • Technological Innovation: The Swoop system, which has received FDA clearance, offers AI-powered point-of-care brain imaging in various settings such as ICUs, emergency departments, and smaller community hospitals, thereby improving accessibility to medical services.
  • Market Outlook: Horizon's Chief Investment Officer Paul Seitz noted that Hyperfine's technology platform expands access to brain imaging in environments where conventional MRI is not feasible, showcasing strong clinical and economic evidence that indicates a broad commercial opportunity.
  • Global Expansion Plans: Hyperfine CEO Maria Sainz stated that this financing will accelerate the commercial expansion of the Swoop system across hospitals and clinics, aiming to provide high clinical and economic value MRI services for acute and chronic brain conditions.
moomoo
8.5
03-23moomoo
Horizon Grants $40 Million Loan Facility to Hyperfine, with $15 Million Disbursed at Closing
  • Loan Facility Announcement: Hyperfine Inc. has secured a $40 million loan facility to support its operations and growth.

  • Funding Details: The loan is backed by a $15 million funding commitment that was finalized at closing.

Wall Street analysts forecast HYPR stock price to rise
1 Analyst Rating
Wall Street analysts forecast HYPR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
2.00
Averages
2.00
High
2.00
Current: 0.000
sliders
Low
2.00
Averages
2.00
High
2.00
BTIG
Buy
initiated
$2
AI Analysis
2026-04-29
Reason
BTIG
Price Target
$2
AI Analysis
2026-04-29
initiated
Buy
Reason
BTIG initiated coverage of Hyperfine with a Buy rating and $2 price target. The company's Swoop System enables point-of-care brain MRI at the bedside, expanding access to MRI imaging by eliminating the need for a shielded room, specialized staff, and patient transport, and the next-generation Swoop V2, cleared in May 2025, paired with the 11th-generation Optive AI software release in December 2025, offers a significant step forward in image quality and clinical utility, the analyst tells investors in a research note.
Lake Street
Buy
maintain
$2
2026-03-19
Reason
Lake Street
Price Target
$2
2026-03-19
maintain
Buy
Reason
Lake Street raised the firm's price target on Hyperfine to $2.50 from $2 and keeps a Buy rating on the shares. Q4 "marked a step-function in system placements, and we think represents an inflection to Hyperfine 2.0," the analyst tells investors following the company's quarterly report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HYPR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Hyperfine Inc (HYPR.O) is 0.00, compared to its 5-year average forward P/E of -1.93. For a more detailed relative valuation and DCF analysis to assess Hyperfine Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.93
Current PE
0.00
Overvalued PE
-0.75
Undervalued PE
-3.12

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.72
Current EV/EBITDA
-3.54
Overvalued EV/EBITDA
1.09
Undervalued EV/EBITDA
-2.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
7.24
Current PS
6.30
Overvalued PS
15.65
Undervalued PS
-1.17

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

What’s the best penny stock
Intellectia · 45 candidates
Price: $0.50 - $5.00Market Cap Category: small, microRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
XRX logo
XRX
Xerox Holdings Corp
353.10M
ESPR logo
ESPR
Esperion Therapeutics Inc
800.53M
RDZN logo
RDZN
Roadzen Inc
176.85M
VLN logo
VLN
Valens Semiconductor Ltd
246.38M
HYPR logo
HYPR
Hyperfine Inc
184.23M
CERS logo
CERS
Cerus Corp
545.00M
take me to stock radar
Intellectia · 53 candidates
Region: USPrice: $1.00 - $30.00Volume: >= 1,000,000Price Change Pct: $-25.00 - $25.00Relative Vol: >= 2List Exchange: XNYS, XNAS
Ticker
Name
Market Cap$
top bottom
SATL logo
SATL
Satellogic Inc
729.00M
HUYA logo
HUYA
HUYA Inc
1.01B
GNTA logo
GNTA
Genenta Science SPA
30.70M
ATOM logo
ATOM
Atomera Inc
105.50M
BAER logo
BAER
Bridger Aerospace Group Holdings Inc
173.85M
UROY logo
UROY
Uranium Royalty Corp
683.86M

Whales Holding HYPR

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Hyperfine Inc (HYPR) stock price today?

The current price of HYPR is 1.69 USD — it has increased 0.6

What is Hyperfine Inc (HYPR)'s business?

Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.

What is the price predicton of HYPR Stock?

Wall Street analysts forecast HYPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPR is2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Hyperfine Inc (HYPR)'s revenue for the last quarter?

Hyperfine Inc revenue for the last quarter amounts to 5.29M USD, increased 128.05

What is Hyperfine Inc (HYPR)'s earnings per share (EPS) for the last quarter?

Hyperfine Inc. EPS for the last quarter amounts to -0.06 USD, decreased -57.14

How many employees does Hyperfine Inc (HYPR). have?

Hyperfine Inc (HYPR) has 102 emplpoyees as of May 11 2026.

What is Hyperfine Inc (HYPR) market cap?

Today HYPR has the market capitalization of 166.50M USD.